Ctrl Worx Watch List › Company

BioScience Health Innovations, Inc. (BHIC): material weakness open at least 2,159 days

By , Ctrl Worx™. Built from its own SEC filings. How the Clock works.

BioScience Health Innovations, Inc. reported ineffective internal control over financial reporting because of a material weakness in 22 filings since Jan 14, 2021. The latest was its 10-Q for the period ended Jun 30, 2026.

Ctrl Worx Watch List™ status

On the Clock
5.9 yearsopen since at least Nov 30, 2020
10-Q, Aug 7, 2026latest filing that reports the weakness. Read it on SEC EDGAR
#45 of 1,250on the Clock by time open, tied with 14 other companies that share its start date. See the Clock

Still filing, and no annual report of its own says the weakness is fixed.

Checked against SEC EDGAR: Oct 29, 2026 · Entry #11504

Filings with a weakness22
First in our dataJan 14, 2021
AuditorMac Accounting Group & CPAs, LLP

Causes the company named

Segregation of duties · 22Accounting expertise and resources · 22Entity-level and governance · 18Financial close and reporting · 11ITGC: general · 5

Insufficient accounting resources, inadequate segregation of duties, lack of independent board oversight, and undocumented control policies.

What the latest filing says

The material weaknesses identified during management’s assessment were (i) a lack of sufficient internal accounting resources; (ii) a lack of segregation of duties to ensure adequate review of financial statement preparation, (iii) lack of an independent board of directors or audit committee, and (iv) lack of written documentation of our internal control policies and procedures. In light of these material weaknesses, management has concluded that we did not maintain effective internal control over financial reporting at the Evaluation Date. We plan to rectify these weaknesses by establishing written policies and procedures for our internal control of financial reporting and hiring additional accounting personnel at such time as we raise sufficient capital to do so. There were no changes in controls during the quarter ended June 30, 2026. 22 Table of Contents [...]

From the controls section of the 10-Q filed Aug 7, 2026. Read the full filing on SEC EDGAR.

Company response: BioScience Health Innovations, Inc. can send a statement or a link to its remediation update to russell@ctrlworx.com. We post it here, unedited and dated.

Filings

FiledFormPeriodControlsCausesFiling
Aug 7, 202610-QJun 30, 2026Not effectiveSegregation of duties; Financial close and reporting; Accounting expertise and resources; Entity-level and governanceEDGAR
May 11, 202610-QMar 31, 2026Not effectiveSegregation of duties; Financial close and reporting; Accounting expertise and resources; Entity-level and governanceEDGAR
Mar 30, 202610-KDec 31, 2025Not effectiveSegregation of duties; Accounting expertise and resources; ITGC: general; Entity-level and governanceEDGAR
Oct 27, 202510-QSep 30, 2025Not effectiveSegregation of duties; Financial close and reporting; Accounting expertise and resources; Entity-level and governanceEDGAR
Aug 7, 202510-QJun 30, 2025Not effectiveSegregation of duties; Financial close and reporting; Accounting expertise and resources; Entity-level and governanceEDGAR
May 8, 202510-QMar 31, 2025Not effectiveSegregation of duties; Financial close and reporting; Accounting expertise and resources; Entity-level and governanceEDGAR
Mar 13, 202510-KDec 31, 2024Not effectiveSegregation of duties; Accounting expertise and resources; ITGC: general; Entity-level and governanceEDGAR
Oct 28, 202410-QSep 30, 2024Not effectiveSegregation of duties; Financial close and reporting; Accounting expertise and resources; Entity-level and governanceEDGAR
Jul 30, 202410-QJun 30, 2024Not effectiveSegregation of duties; Financial close and reporting; Accounting expertise and resources; Entity-level and governanceEDGAR
Mar 29, 202410-KDec 31, 2023Not effectiveSegregation of duties; Accounting expertise and resources; ITGC: general; Entity-level and governanceEDGAR
Oct 31, 202310-QSep 30, 2023Not effectiveSegregation of duties; Financial close and reporting; Accounting expertise and resources; Entity-level and governanceEDGAR
Aug 11, 202310-QJun 30, 2023Not effectiveSegregation of duties; Financial close and reporting; Accounting expertise and resources; Entity-level and governanceEDGAR
May 15, 202310-QMar 31, 2023Not effectiveSegregation of duties; Accounting expertise and resources; Entity-level and governanceEDGAR
Jan 13, 202310-QNov 30, 2022Not effectiveSegregation of duties; Accounting expertise and resources; Entity-level and governanceEDGAR
Nov 1, 202210-KAug 31, 2022Not effectiveSegregation of duties; Accounting expertise and resources; ITGC: general; Entity-level and governanceEDGAR
Jul 13, 202210-QMay 31, 2022Not effectiveSegregation of duties; Financial close and reporting; Accounting expertise and resources; Entity-level and governanceEDGAR
Apr 14, 202210-QFeb 28, 2022Not effectiveSegregation of duties; Financial close and reporting; Accounting expertise and resources; Entity-level and governanceEDGAR
Jan 14, 202210-QNov 30, 2021Not effectiveSegregation of duties; Accounting expertise and resourcesEDGAR
Nov 26, 202110-KAug 31, 2021Not effectiveSegregation of duties; Accounting expertise and resources; ITGC: general; Entity-level and governanceEDGAR
Jul 14, 202110-QMay 31, 2021Not effectiveSegregation of duties; Accounting expertise and resourcesEDGAR
Apr 13, 202110-QFeb 28, 2021Not effectiveSegregation of duties; Accounting expertise and resourcesEDGAR
Jan 14, 202110-QNov 30, 2020Not effectiveSegregation of duties; Accounting expertise and resourcesEDGAR

Others on the Clock in the same industry

By SEC industry code: 7374, Services-Computer Processing & Data Preparation, then related codes.

Follow BHIC for free

Get an email when BioScience Health Innovations, Inc files a 10-K or 10-Q that reports a material weakness, or says its controls are effective again.

Want the next one the day it's filed?

MW Pro sends an alert the day a company you follow reports a material weakness or says it fixed one. Founding price $990 a year.

Join the MW Pro waitlistLook up any company in Controls Radar™

Watch List Weekly: new material weaknesses, fixes and the longest-running cases, every Monday.

One email to confirm, then one email each Monday. Every email has a one-click unsubscribe. Privacy policy

Based on public SEC filings. Causes are grouped into standard categories by Ctrl Worx. The filings are the authority. Ctrl Worx is not affiliated with BioScience Health Innovations, Inc. or the SEC. Not investment advice. Why you can rely on the Watch List.